"You can checkout any time you like, but you can never leave." That is the scenario for smokers who develop COPD.

U.S. Food and Drug Administration (FDA) officials have approved an updated drug label for smoking cessation medication varenicline (Chantix) with stronger warnings.

A new therapy for people with chronic obstructive pulmonary disease, or COPD, has been approved by the U.S. Food and Drug Administration (FDA).

There's no question that the wildfire sweeping across drought-stricken areas of the United States can be devastating. New research suggests that more than your property is at risk.

Women in menopause are more likely to have bone fractures than men. A recent medical review indicates that older men with chronic obstructive pulmonary disease (COPD) who use inhaled-corticosteroids can join women with the bone fracture risk.

Johns Hopkins-led research suggests using Respimat Soft Mist Inhaler to deliver tiotropium (Spiriva) to chronic obstructive pulmonary disorder (COPD) patients is linked to a 52 percent increase in risk of death.

Patients with chronic obstructive pulmonary disease (COPD) may also suffer from chronic hypercapnic respiratory failure (CHRF).

Patients with chronic obstructive pulmonary disease (COPD) often have difficulty exercising due to their diminished lung capacity.

What does a little confidence do for a person? Well, a great deal. With confidence comes a willingness to display your stuff, do your thing, tackle your world, and shake your tail feathers.

All types of smoking is considered a major risk factor for developing chronic obstructive pulmonary disease (COPD), but not all smokers develop COPD.